Marylène Lejeune

9PUBLICATIONS
56CO-AUTHORS
Tumour immunologyInnate immunityMolecular targetsPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 04, 2026
Longitudinal evaluation of tumor-infiltrating lymphocyte scoring using automated region of interest registration in breast cancer.

|Mar 20, 2025
Type I interferon autoantibody footprints reveal neutralizing mechanisms and allow inhibitory decoy design.

Kevin Groen, Roger Kuratli, Jannik Enkelmann

|May 28, 2024
Enhancing AI Research for Breast Cancer: A Comprehensive Review of Tumor-Infiltrating Lymphocyte Datasets.

Alessio Fiorin, Carlos López Pablo, Marylène Lejeune

|Jul 29, 2023
Matrix Metalloproteinase-9 Expression Is Associated with the Absence of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients.

Marylène Lejeune, Laia Reverté, Noèlia Gallardo

|Feb 11, 2023
Prognostic Implications of the Residual Tumor Microenvironment after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients without Pathological Complete Response.

Marylène Lejeune, Laia Reverté, Esther Sauras

|Jun 21, 2022
Lenalidomide plus R-GDP (R2-GDP) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Final Results of the R2-GDP-GOTEL Trial and Immune Biomarker Subanalysis.

Natalia Palazón-Carrión, Alejandro Martín García-Sancho, Esteban Nogales-Fernández

Pageof 2

Frequent Collaborators

6 joint publications

Ramon Bosch-Príncep

4 joint publications

Carlos López-Pablo

3 joint publications

Anna Korzyńska

3 joint publications

Noèlia Gallardo-Borràs